Literature DB >> 22491866

Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin.

E McDade1, B F Boeve, T M Burrus, B P Boot, K Kantarci, J Fields, V J Lowe, P Peller, D Knopman, M Baker, N Finch, R Rademakers, R Petersen.   

Abstract

OBJECTIVE: To report the phenotypic characterization of monozygotic twins with mutations encoding progranulin (PGRN).
METHODS: We studied a twin pair with an exon 4 gene deletion in the PGRN gene. Both twins had clinical and neuropsychological examinations as well as structural MRI and fluorodeoxyglucose PET (FDG-PET) scans. PGRN gene sequencing was performed followed by progranulin ELISA in plasma.
RESULTS: Both twins manifested symptoms within 3 years of each other, with early behavioral, language, dysexecutive, and memory problems. MRI and FDG-PET imaging demonstrated a strikingly similar topography of findings with clear left hemisphere predominance. Serum progranulin levels in both were well below those from a normal population sample.
CONCLUSIONS: Compared with the heterogeneity seen in many families with PGRN mutations, these monozygotic twins demonstrated strong clinical, neuroimaging, and serum progranulin level similarities, demonstrating the importance of shared genetic profiles beyond environmental influences in the symptomatic expression of the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491866      PMCID: PMC3324318          DOI: 10.1212/WNL.0b013e318251594c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Prominent phenotypic variability associated with mutations in Progranulin.

Authors:  Brendan J Kelley; Wael Haidar; Bradley F Boeve; Matt Baker; Neill R Graff-Radford; Thomas Krefft; Andrew R Frank; Clifford R Jack; Maria Shiung; David S Knopman; Keith A Josephs; Sotirios A Parashos; Rosa Rademakers; Mike Hutton; Stuart Pickering-Brown; Jennifer Adamson; Karen M Kuntz; Dennis W Dickson; Joseph E Parisi; Glenn E Smith; Robert J Ivnik; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2007-10-18       Impact factor: 4.673

2.  Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation.

Authors:  G Gliebus; E H Bigio; K Gasho; M Mishra; D Caplan; M-M Mesulam; C Geula
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

3.  Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology.

Authors:  B F Boeve; D M Maraganore; J E Parisi; R J Ivnik; B F Westmoreland; D W Dickson; M Hutton; J Hardy; R J Caselli; R C Petersen
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

4.  Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families.

Authors:  Marsel Mesulam; Nancy Johnson; Thomas A Krefft; Jennifer M Gass; Ashley D Cannon; Jennifer L Adamson; Eileen H Bigio; Sandra Weintraub; Dennis W Dickson; Michael L Hutton; Neill R Graff-Radford
Journal:  Arch Neurol       Date:  2007-01

5.  The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.

Authors:  Chang-En Yu; Thomas D Bird; Lynn M Bekris; Thomas J Montine; James B Leverenz; Ellen Steinbart; Nichole M Galloway; Howard Feldman; Randall Woltjer; Carol A Miller; Elisabeth McCarty Wood; Murray Grossman; Leo McCluskey; Christopher M Clark; Manuela Neumann; Adrian Danek; Douglas R Galasko; Steven E Arnold; Alice Chen-Plotkin; Anna Karydas; Bruce L Miller; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg; Vivianna M Van Deerlin
Journal:  Arch Neurol       Date:  2010-02

6.  TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.

Authors:  N Finch; M M Carrasquillo; M Baker; N J Rutherford; G Coppola; M Dejesus-Hernandez; R Crook; T Hunter; R Ghidoni; L Benussi; J Crook; E Finger; K J Hantanpaa; A M Karydas; P Sengdy; J Gonzalez; W W Seeley; N Johnson; T G Beach; M Mesulam; G Forloni; A Kertesz; D S Knopman; R Uitti; C L White; R Caselli; C Lippa; E H Bigio; Z K Wszolek; G Binetti; I R Mackenzie; B L Miller; B F Boeve; S G Younkin; D W Dickson; R C Petersen; N R Graff-Radford; D H Geschwind; R Rademakers
Journal:  Neurology       Date:  2010-12-22       Impact factor: 9.910

7.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

Authors:  S Minoshima; K A Frey; R A Koeppe; N L Foster; D E Kuhl
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

9.  Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.

Authors:  Isabelle Le Ber; Agnès Camuzat; Didier Hannequin; Florence Pasquier; Eric Guedj; Anne Rovelet-Lecrux; Valérie Hahn-Barma; Julie van der Zee; Fabienne Clot; Serge Bakchine; Michèle Puel; Mustapha Ghanim; Lucette Lacomblez; Jacqueline Mikol; Vincent Deramecourt; Pascal Lejeune; Vincent de la Sayette; Serge Belliard; Martine Vercelletto; Christian Meyrignac; Christine Van Broeckhoven; Jean-Charles Lambert; Patrice Verpillat; Dominique Campion; Marie-Odile Habert; Bruno Dubois; Alexis Brice
Journal:  Brain       Date:  2008-02-01       Impact factor: 13.501

10.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

  10 in total
  7 in total

1.  Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers.

Authors:  Claudia Jacova; Ging-Yuek R Hsiung; Itthipol Tawankanjanachot; Katie Dinelle; Siobhan McCormick; Marjorie Gonzalez; Hyunsoo Lee; Pheth Sengdy; Phoenix Bouchard-Kerr; Matthew Baker; Rosa Rademakers; Vesna Sossi; A Jon Stoessl; Howard H Feldman; Ian R Mackenzie
Journal:  Neurology       Date:  2013-09-04       Impact factor: 9.910

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

3.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02

Review 4.  Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations.

Authors:  Bradley F Boeve; Howard Rosen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia.

Authors:  Maria Göbel; Lewin Eisele; Michael Möllmann; Andreas Hüttmann; Patricia Johansson; René Scholtysik; Manuela Bergmann; Raymonde Busch; Hartmut Döhner; Michael Hallek; Till Seiler; Stephan Stilgenbauer; Ludger Klein-Hitpass; Ulrich Dührsen; Jan Dürig
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

Review 6.  A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.

Authors:  Takashi Hosaka; Kazuhiro Ishii; Takeshi Miura; Naomi Mezaki; Kensaku Kasuga; Takeshi Ikeuchi; Akira Tamaoka
Journal:  BMC Neurol       Date:  2017-09-15       Impact factor: 2.474

Review 7.  Molecular imaging biomarkers in familial frontotemporal lobar degeneration: Progress and prospects.

Authors:  Ruihan Wang; Hui Gao; Hongsheng Xie; Zhiyun Jia; Qin Chen
Journal:  Front Neurol       Date:  2022-08-16       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.